Felipharm

Active

Private limited companyfounded 2024active for 2 yearsTijl-en-Nelestraat 49, 2300 Turnhout, BelgiumKBO/BCE: BE 1010.821.954

Summary

Felipharm has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €54,701 and a net result of €43,625. Its solvency ranks better than 73% of 9,627 sector peers (NACE 82, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Risk analysisFollow Report Compare

FelipharmActiveChecked score 98/100

Risk analysis Report Compare

History

Felipharm was incorporated on 27 June 2024 as a private limited company by one natural person, with a starting capital of €1,500.¹² Since 2024, JACOBS,Sofie Maria Willy Rita has served as director of the company.² The company has filed 2 sets of annual accounts, the latest for financial year 2025.³

Acts, filings and financial milestones

All 4Financial 1Gazette 1Filings 2

Next filing, financial year 2026, expected by 31-07-2027

2026

10-02

NBB filing Annual accounts filed

financial year 2025 · micro format

2025

31-12

Financial Liquidity doublescurrent ratio 3.69

Current ratio from 1.83 to 3.69.

28-02

NBB filing Annual accounts filed

financial year 2024 · micro format

2024

01-07

Gazette deed Incorporation

Appointment: JACOBS,Sofie Maria Willy Rita (director) · Founder · Founding capital5 facts ▸

Incorporation, “Felipharm” (deed in Dutch)
Founder, JACOBS,Sofie Maria Willy Rita
Founding capital, €1,500
Director appointment, JACOBS,Sofie Maria Willy Rita (director (not named in the articles))
Pre-incorporation commitments, “takeover, alle verbintenissen,verplichtingen en activiteiten in naam en voor rekening van vennootschap in oprichting” (deed in Dutch)

Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.

1 of 1 deed read